• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种不同的促静脉回流疗法作为晚期痔病患者手术过渡治疗的疗效前瞻性研究。

A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease.

作者信息

Orefice Raffaele, Litta Francesco, Parello Angelo, De Simone Veronica, Campennì Paola, Marra Angelo Alessandro, Ratto Carlo

机构信息

Proctology Unit, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo A. Gemelli, 8, 00168 Rome, Italy.

Department of Medicine and Translational Surgery, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168 Rome, Italy.

出版信息

J Clin Med. 2021 Apr 7;10(8):1549. doi: 10.3390/jcm10081549.

DOI:10.3390/jcm10081549
PMID:33917023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8067694/
Abstract

The aims of this study were to evaluate the efficacy of two different phlebotonic therapies, preoperatively administered in advanced hemorrhoidal disease (HD) patients with recommendation for surgery, and to assess patient satisfaction after treatment. In this prospective observational study, 100 patients were preoperatively treated either with micronized purified flavonoid fraction (group A) or sublingual nano-emulsion flavonoid (group B). HD symptoms, local inflammation signs and patients' satisfaction were evaluated at baseline visit (T0), after 4 weeks of therapy (T1) and 8 weeks after its discontinuation (T2). In group A, a significant improvement for all HD symptoms and inflammation signs was observed after therapy (T1), followed by a reduction of efficacy in T2, except for itching and edema. In group B, therapy had a significant benefit on symptoms and local inflammation at T1, which persisted after its discontinuation for all symptoms, and edematous hemorrhoids. In both groups, the satisfaction rate was "good" in 60% of patients and patients were statistically significant more satisfied at T1 compared with T2 ( = 0.0001). No adverse events were recorded. Preoperative treatment was safe and useful to optimize patients' clinical condition prior to surgery.

摘要

本研究的目的是评估两种不同的促静脉回流疗法在有手术指征的晚期痔病(HD)患者术前应用的疗效,并评估治疗后患者的满意度。在这项前瞻性观察研究中,100例患者术前分别接受微粉化纯化黄酮类成分治疗(A组)或舌下纳米乳剂黄酮治疗(B组)。在基线访视(T0)、治疗4周后(T1)以及停药8周后(T2)评估HD症状、局部炎症体征和患者满意度。在A组,治疗后(T1)所有HD症状和炎症体征均有显著改善,随后在T2疗效降低,但瘙痒和水肿除外。在B组,治疗在T1时对症状和局部炎症有显著益处,停药后所有症状及水肿性痔的改善仍持续存在。在两组中,60%的患者满意度为“良好”,且与T2相比,患者在T1时的满意度在统计学上有显著提高(P = 0.0001)。未记录到不良事件。术前治疗对于优化患者术前临床状况是安全且有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/0f793eb48650/jcm-10-01549-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/30a5487b2a8b/jcm-10-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/b22ca1587373/jcm-10-01549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/f37c8392cbbe/jcm-10-01549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/00d422d0aa08/jcm-10-01549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/8a5d482525d8/jcm-10-01549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/6d4459b42f30/jcm-10-01549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/0f793eb48650/jcm-10-01549-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/30a5487b2a8b/jcm-10-01549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/b22ca1587373/jcm-10-01549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/f37c8392cbbe/jcm-10-01549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/00d422d0aa08/jcm-10-01549-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/8a5d482525d8/jcm-10-01549-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/6d4459b42f30/jcm-10-01549-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524c/8067694/0f793eb48650/jcm-10-01549-g007.jpg

相似文献

1
A Prospective Study on the Efficacy of Two Different Phlebotonic Therapies as a Bridge to Surgery in Patients with Advanced Hemorrhoidal Disease.两种不同的促静脉回流疗法作为晚期痔病患者手术过渡治疗的疗效前瞻性研究。
J Clin Med. 2021 Apr 7;10(8):1549. doi: 10.3390/jcm10081549.
2
Effectiveness of preoperative micronized purified flavonoid fraction treatment and sucralfate-based rectal ointment on hemorrhoidal disease: A case-matched analysis.术前应用微粒化纯化黄酮类混合物治疗和硫酸酯直肠软膏治疗痔病的效果:病例匹配分析。
Tech Coloproctol. 2024 Sep 17;28(1):126. doi: 10.1007/s10151-024-02998-0.
3
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of , , and for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study.微粉化黄酮类化合物联合维生素C及[此处原文缺失部分植物名称]提取物治疗Ⅱ、Ⅲ度痔病患者以减轻痔症状的疗效与安全性评估:一项回顾性真实世界研究
Front Pharmacol. 2021 Dec 14;12:773320. doi: 10.3389/fphar.2021.773320. eCollection 2021.
4
An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study).一项评估痔病保守治疗的国际观察性研究:CHORALIS(急性痔病评估国际研究)的结果。
J Comp Eff Res. 2024 Oct;13(10):e240070. doi: 10.57264/cer-2024-0070. Epub 2024 Aug 12.
5
Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment.采用微粒化纯化黄酮类化合物和硫酸锌软膏治疗痔疮病。
Acta Biomed. 2020 Mar 19;91(1):139-141. doi: 10.23750/abm.v91i1.9361.
6
Doppler-guided hemorrhoidal dearterialization with laser (HeLP): a prospective analysis of data from a multicenter trial.多普勒引导痔动脉结扎术联合激光(HeLP):多中心试验前瞻性数据分析。
Tech Coloproctol. 2018 Aug;22(8):635-643. doi: 10.1007/s10151-018-1839-5. Epub 2018 Aug 29.
7
Role of a Micronized Purified Flavonoid Fraction as an Adjuvant Treatment to Rubber Band Ligation for the Treatment of Patients With Hemorrhoidal Disease: A Longitudinal Cohort Study.微粉化纯化类黄酮组分作为橡皮筋结扎术辅助治疗痔病患者的作用:一项纵向队列研究
Ann Coloproctol. 2019 Dec;35(6):306-312. doi: 10.3393/ac.2018.09.18. Epub 2019 Dec 31.
8
Relief of hemorrhoid symptoms: pilot study of a new topical ally.缓解痔疮症状:一种新型局部用药的初步研究
G Chir. 2020 Jan-Feb;41(1):118-125.
9
Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.前瞻性、随机、对照、观察者盲法试验:比较联合红外线光凝术与微粉化纯化黄酮类化合物分别单独使用对痔病的治疗效果。
Clin Ther. 2005 Jun;27(6):746-54. doi: 10.1016/j.clinthera.2005.06.016.
10
Minimal Open Hemorrhoidectomy Versus Transanal Hemorrhoidal Dearterialization: The Effect on Symptoms: An Open-Label Randomized Controlled Trial.微创外剥内扎术与经肛痔动脉结扎术治疗痔病的疗效比较:症状改善情况的观察:一项开放标签随机对照临床试验。
Dis Colon Rectum. 2020 May;63(5):655-667. doi: 10.1097/DCR.0000000000001588.

引用本文的文献

1
Utilisation of Deep Neural Networks for Estimation of Cajal Cells in the Anal Canal Wall of Patients with Advanced Haemorrhoidal Disease Treated by LigaSure Surgery.利用深度神经网络估计接受LigaSure手术治疗的晚期痔病患者肛管壁中的Cajal细胞。
Cells. 2025 Apr 5;14(7):550. doi: 10.3390/cells14070550.

本文引用的文献

1
Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.痔疮的保守治疗:一项观察性多中心研究结果。
Adv Ther. 2018 Nov;35(11):1979-1992. doi: 10.1007/s12325-018-0794-x. Epub 2018 Oct 1.
2
Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.类黄酮混合物(地奥司明、曲克芦丁、芦丁、橙皮苷、槲皮素)治疗Ⅰ-Ⅲ度痔病:一项双盲多中心前瞻性对照研究。
Int J Colorectal Dis. 2018 Nov;33(11):1595-1600. doi: 10.1007/s00384-018-3102-y. Epub 2018 Jun 22.
3
Treatment of hemorrhoids: A coloproctologist's view.
痔疮的治疗:一位结直肠外科医生的观点。
World J Gastroenterol. 2015 Aug 21;21(31):9245-52. doi: 10.3748/wjg.v21.i31.9245.
4
Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.类黄酮混合物(地奥司明、曲克芦丁、橙皮苷)治疗急性痔病:一项前瞻性、随机、三盲、对照试验。
Tech Coloproctol. 2015 Jun;19(6):339-45. doi: 10.1007/s10151-015-1302-9. Epub 2015 Apr 19.
5
Pharmacological treatment of hemorrhoids: a narrative review.痔的药物治疗:叙述性综述。
Expert Opin Pharmacother. 2013 Dec;14(17):2343-9. doi: 10.1517/14656566.2013.836181. Epub 2013 Sep 12.
6
Phlebotonics for haemorrhoids.用于治疗痔疮的静脉疗法
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004322. doi: 10.1002/14651858.CD004322.pub3.
7
Practice parameters for the management of hemorrhoids (revised 2010).痔管理的实践参数(2010年修订)
Dis Colon Rectum. 2011 Sep;54(9):1059-64. doi: 10.1097/DCR.0b013e318225513d.
8
How we can improve patients' comfort after Milligan-Morgan open haemorrhoidectomy.如何提高 Milligan-Morgan 开放式痔切除术患者术后舒适度。
World J Gastroenterol. 2011 Mar 21;17(11):1448-56. doi: 10.3748/wjg.v17.i11.1448.
9
The treatment of hemorrhoids: guidelines of the Italian Society of Colorectal Surgery.痔的治疗:意大利结直肠外科学会指南
Tech Coloproctol. 2006 Oct;10(3):181-6. doi: 10.1007/s10151-006-0277-y. Epub 2006 Sep 20.
10
The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes.微粉化纯化黄酮类成分对急性痔发作治疗的影响。
Curr Med Res Opin. 2006 Jun;22(6):1141-7. doi: 10.1185/030079906X104803.